Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A camptothecin-based dimer compound, its preparation and application

A technology of dimer and camptothecin, applied in the field of medicine, can solve the problems of difficult systemic drug administration, many adverse reactions, hindering application, etc., and achieve the effects of enhancing solubility, reducing toxicity, and reducing tumor weight

Active Publication Date: 2021-11-09
HUAZHONG UNIV OF SCI & TECH
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Camptothecin has significant anticancer properties, but the π-π interaction between the planar five-membered ring and the aromatic ring in its structure makes it less soluble, difficult to administer systemically, has many adverse reactions, and has severe bone marrow suppression Toxicity hinders its clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A camptothecin-based dimer compound, its preparation and application
  • A camptothecin-based dimer compound, its preparation and application
  • A camptothecin-based dimer compound, its preparation and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0043] The present invention also provides a method for preparing the dimer compound, comprising the following steps:

[0044] (1) The hydroxyl group in the camptothecin structural formula is converted into a carbonyl chloride compound by a substitution reaction; then the carbonyl chloride compound is esterified with an alkyl diol containing a disulfide bond, so that the camptothecin and the disulfide-containing The alkyl diols of bonds are connected by carbonate bonds to obtain intermediate products;

[0045] (2) After the intermediate product described in step (1) is separated and purified, the hydroxyl contained in its structure undergoes a substitution reaction and is converted into an activated product, which is a carbonyl chloride compound; then the carbonyl chloride compound is substituted with NLG919 Reaction, so that the intermediate product and NLG919 are connected through a carbonate bond, and the obtained product is separated and purified to obtain the dimer compou...

Embodiment 1

[0060] as per figure 1 The preparation of the compound CN shown in the formula (2) according to the schematic flow diagram is carried out according to the following steps:

[0061] (1) Reaction of camptothecin with 2,2'-dithiodiethanol: dissolve camptothecin (1mmol, 348.34mg), triphosgene (1 / 3mmol, 98.91mg) in 20ml of dichloromethane, add 4-di Aminopyridine (1 mmol, 122.17 mg) was reacted on ice in the dark for 30 minutes, and 2,2'-dithiodiethanol (1 mmol, 154.25 mg) was added to react at room temperature in the dark for 12 h.

[0062] (2) Extract the product obtained in (1) with 0.1M hydrochloric acid aqueous solution, saturated saline, and ultrapure water, separate the organic phase, and dry in a vacuum oven at 37°C to remove the organic solvent and dry.

[0063] (3) Dissolve the product (1eq) and triphosgene (1 / 3eq) obtained in (2) in dichloromethane, add 4-dimethylaminopyridine (1eq) and react for 30 minutes, then add NLG919 (1eq) to react.

[0064] (4) Extract the produ...

Embodiment 2

[0067] Reduction-responsive studies of compounds.

[0068] Take a small amount of compound CN in 100 mM GSH aqueous solution and stir for 12 h. The stirred solution was analyzed by mass spectrometry, and the mass spectrometry results were as follows: Figure 4 shown. The results of mass spectrometry showed that compound CN could be degraded to the original camptothecin and NLG919 under reducing conditions.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and more specifically relates to a camptothecin-based dimer compound, its preparation and application. The dimer compound has a structure shown in formula (1): in formula (1), m is an integer of 1-4, and n is an integer of 1-4. The dimer compound connects camptothecin and the small immunomodulatory molecule NLG919 through a reductive disulfide bond, realizes the combination of tumor chemotherapy and immunotherapy, and enhances the antitumor efficacy. The compound prepared by the present invention can be reduced to the original camptothecin and NLG919 under reducing conditions, and exerts good antitumor activity in tumors such as liver cancer, breast cancer, colon cancer, melanoma and ovarian cancer. The activity of amine 2,3 oxygenase increases the maturation of DC cells, reduces the number of immunosuppressive Treg cells, reduces the resistance of tumor stem cells to camptothecin, and enhances the tumor immune response.

Description

technical field [0001] The invention belongs to the technical field of medicine, and more specifically relates to a camptothecin-based dimer compound, its preparation and application. Background technique [0002] Tumor is the most important factor threatening human health. Chemotherapy drugs are currently one of the main means of treating various tumors, which mainly exert anti-tumor effects by inhibiting cell growth and / or by cytotoxicity. The immune response elicited by chemotherapeutic drugs can also significantly enhance the overall antitumor effect. However, the immune response induced by chemotherapy is usually limited by various negative feedback regulatory mechanisms that are upregulated during tumor development or tumor treatment. Blocking these negative feedback regulatory pathways with immune drugs is currently the main strategy for reactivating anti-tumor immune responses. . [0003] Camptothecin (CPT), a cytotoxic quinoline alkaloid, can form a relatively st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D519/00A61P35/00A61K31/4745
CPCA61P35/00C07D519/00
Inventor 李子福杨祥良万江陵官建坤
Owner HUAZHONG UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com